Back to Journals » Psoriasis: Targets and Therapy

Psoriasis: Targets and Therapy


Journal Articles:

- 55 records -

Clinical utility of ixekizumab in the treatment of moderate-to-severe plaque psoriasis

Sekhon S, Jeon C, Nakamura M, Yan D, Afifi L, Bhutani T, Levin E

Psoriasis: Targets and Therapy 2017, 7:65-72

Published Date: 16 November 2017

Hepatitis B reactivation in psoriasis patients treated with anti-TNF agents: prevention and management

Cannizzaro MV, Franceschini C, Esposito M, Bianchi L, Giunta A

Psoriasis: Targets and Therapy 2017, 7:35-40

Published Date: 15 April 2017

Local effects of adipose tissue in psoriasis and psoriatic arthritis

Kruglikov IL, Wollina U

Psoriasis: Targets and Therapy 2017, 7:17-25

Published Date: 3 February 2017

The metabolomics of psoriatic disease

Yan D, Afifi L, Jeon C, Trivedi M, Chang HW, Lee K, Liao W

Psoriasis: Targets and Therapy 2017, 7:1-15

Published Date: 31 January 2017

Excimer laser for the treatment of psoriasis: safety, efficacy, and patient acceptability

Abrouk M, Levin E, Brodsky M, Gandy JR, Nakamura M, Zhu TH, Farahnik B, Koo J, Bhutani T

Psoriasis: Targets and Therapy 2016, 6:165-173

Published Date: 12 December 2016

Pustular psoriasis: pathophysiology and current treatment perspectives

Benjegerdes KE, Hyde K, Kivelevitch D, Mansouri B

Psoriasis: Targets and Therapy 2016, 6:131-144

Published Date: 12 September 2016

Psoriasis in children

Pinson R, Sotoodian B, Fiorillo L

Psoriasis: Targets and Therapy 2016, 6:121-129

Published Date: 20 October 2016

Psoriasis patients’ experiences concerning medical adherence to treatment with topical corticosteroids

Svendsen MT, Andersen KE, Andersen F, Hansen J, Pottegård A, Johannessen H

Psoriasis: Targets and Therapy 2016, 6:113-119

Published Date: 23 August 2016

Combining biologic and phototherapy treatments for psoriasis: safety, efficacy, and patient acceptability

Farahnik B, Patel V, Beroukhim K, Zhu TH, Abrouk M, Nakamura M, Singh R, Lee K, Bhutani T, Koo J

Psoriasis: Targets and Therapy 2016, 6:105-111

Published Date: 28 July 2016

Erythrodermic psoriasis: pathophysiology and current treatment perspectives

Singh RK, Lee KM, Ucmak D, Brodsky M, Atanelov Z, Farahnik B, Abrouk M, Nakamura M, Zhu TH, Liao W

Psoriasis: Targets and Therapy 2016, 6:93-104

Published Date: 20 July 2016

Psoriasis and inflammatory bowel disease: links and risks

Vlachos C, Gaitanis G, Katsanos KH, Christodoulou DK, Tsianos E, Bassukas ID

Psoriasis: Targets and Therapy 2016, 6:73-92

Published Date: 20 July 2016

Psoriasis and smoking: links and risks

Naldi L

Psoriasis: Targets and Therapy 2016, 6:65-71

Published Date: 27 May 2016

Assessment and monitoring of biologic drug adverse events in patients with psoriasis

Hanley T, Handford M, Lavery D, Yiu ZZN

Psoriasis: Targets and Therapy 2016, 6:41-54

Published Date: 1 April 2016

Management of scalp psoriasis: current perspectives

Blakely K, Gooderham M

Psoriasis: Targets and Therapy 2016, 6:33-40

Published Date: 29 March 2016

Current knowledge on psoriasis and autoimmune diseases

Ayala-Fontánez N, Soler DC, McCormick TS

Psoriasis: Targets and Therapy 2016, 6:7-32

Published Date: 22 February 2016

Links and risks associated with psoriasis and metabolic syndrome

Liakou AI, Zouboulis CC

Psoriasis: Targets and Therapy 2015, 5:125-128

Published Date: 2 November 2015

Update on the treatment of psoriasis and psoriatic arthritis – role of apremilast

Forchhammer S, Ghoreschi K

Psoriasis: Targets and Therapy 2015, 5:117-124

Published Date: 7 September 2015

Improving patient outcomes in psoriasis: strategies to ensure treatment adherence

Yélamos O, Ros S, Puig L

Psoriasis: Targets and Therapy 2015, 5:109-115

Published Date: 17 July 2015

Psoriasis in pregnancy: challenges and solutions

Vena GA, Cassano N, Bellia G, Colombo D

Psoriasis: Targets and Therapy 2015, 5:83-95

Published Date: 18 May 2015

Epidemiology and treatment of psoriasis: a Brazilian perspective

Duarte GV, Porto-Silva L, Oliveira MdeFP

Psoriasis: Targets and Therapy 2015, 5:55-64

Published Date: 17 April 2015

Psoriasis in childhood: effective strategies to improve treatment adherence

Shah KN, Cortina S, Ernst MM, Kichler JC

Psoriasis: Targets and Therapy 2015, 5:43-54

Published Date: 16 March 2015

Clinical potential of brodalumab in the management of psoriasis: the evidence to date

Sandoval LF, Williams B, Feldman SR

Psoriasis: Targets and Therapy 2015, 5:35-41

Published Date: 11 March 2015

Optimal management of nail disease in patients with psoriasis

Piraccini BM, Starace M

Psoriasis: Targets and Therapy 2015, 5:25-33

Published Date: 9 January 2015

Fumaric acid esters in the management of psoriasis

Balak DMW

Psoriasis: Targets and Therapy 2015, 5:9-23

Published Date: 5 January 2015

Disease burden and patient reported outcomes among patients with moderate to severe psoriasis: an ethnography study

Narayanan S, Guyatt V, Franceschetti A, Hautamaki EL

Psoriasis: Targets and Therapy 2015, 5:1-7

Published Date: 23 December 2014

Epidemiology and treatment of psoriasis: a Chinese perspective

Pan R, Zhang JZ

Psoriasis: Targets and Therapy 2014, 4:37-47

Published Date: 13 October 2014

Emerging treatment options for psoriasis

Taheri A, Sandoval LF, Moradi Tuchayi S, Alinia H, Mansoori P, Feldman SR

Psoriasis: Targets and Therapy 2014, 4:27-35

Published Date: 18 August 2014

Self-management in patients with psoriasis

Pathak SN, Scott PL, West C, Feldman SR

Psoriasis: Targets and Therapy 2014, 4:19-26

Published Date: 10 July 2014

Critical appraisal of adalimumab in the treatment of chronic plaque psoriasis

Nicolazzo D, Kerdel F, Kerdel F

Psoriasis: Targets and Therapy 2014, 4:11-18

Published Date: 24 June 2014

Long-term safety of biologics in the treatment of psoriasis

Panchal MR, Coope H, McKenna DJ, Alexandroff AB

Psoriasis: Targets and Therapy 2014, 4:1-9

Published Date: 12 December 2013

Biologic therapy and tuberculosis: our experience and review of literature

Fabroni C, D'Erme AM, Lotti T

Psoriasis: Targets and Therapy 2013, 3:25-29

Published Date: 3 July 2013

Management of guttate psoriasis in patients with associated streptococcal infection

Karabudak Abuaf O, Dogan B

Psoriasis: Targets and Therapy 2012, 2:89-94

Published Date: 20 November 2012

Safety profiles of topical vitamin D3 in psoriasis patients: a retrospective large-scale study

Yamamoto A, Furuhashi T, Matsumoto K, Morita A

Psoriasis: Targets and Therapy 2012, 2:81-88

Published Date: 15 November 2012

Lipid profile in psoriasis patients

Bhat RM, Pinto HP

Psoriasis: Targets and Therapy 2012, 2:77-80

Published Date: 9 November 2012

Psoriasis: epidemiology, natural history, and differential diagnosis

Basko-Plluska JL, Petronic-Rosic V

Psoriasis: Targets and Therapy 2012, 2:67-76

Published Date: 11 September 2012

Biomarkers in the pathogenesis, diagnosis, and treatment of psoriasis

Molteni S, Reali E

Psoriasis: Targets and Therapy 2012, 2:55-66

Published Date: 4 September 2012

The management of psoriasis through diet

Duarte G, Barbosa LO, Rosa ME

Psoriasis: Targets and Therapy 2012, 2:45-53

Published Date: 7 August 2012

Biologics in the treatment of psoriasis and emerging new therapies in the pipeline

Levy LL, Solomon SM, Emer JJ

Psoriasis: Targets and Therapy 2012, 2:29-43

Published Date: 18 June 2012

Plaque psoriasis in children and adolescents – the role of etanercept

Ricceri F, Tripo L, Pescitelli L, Prignano F

Psoriasis: Targets and Therapy 2012, 2:25-28

Published Date: 11 June 2012

Quality of life issues and measurement in patients with psoriasis

Tan X, Feldman SR, Balkrishnan R

Psoriasis: Targets and Therapy 2012, 2:13-23

Published Date: 21 February 2012

Editorial

Bagel J

Psoriasis: Targets and Therapy 2011, 1:1-2

Published Date: 23 June 2011